Palatin Technologies (PTN) EBT (2010 - 2026)
Palatin Technologies' (PTN) quarterly EBT came in at -$1.4 million in Q1 2026, up 70.04% YoY from -$842719.1 in Q1 2025, and up 80.27% on a QoQ basis from -$7.3 million in Q4 2025.
Palatin Technologies (PTN) EBT (2010 - 2026) Analysis & Trends
Palatin Technologies (PTN) has 17 years of EBT data on file, last reported at -$1.4 million in Q1 2026.
- Quarterly EBT rose 70.04% year-over-year to -$1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.3 million (up 73.13% YoY) and the FY2025 annual result came in at -$87.6 million, down 194.57% from the prior year.
- EBT improved to -$1.4 million in Q1 2026, from -$7.3 million in the prior quarter.
- In the past five years, EBT ranged from a high of $4.7 million in Q3 2025 to a low of -$12.8 million in Q2 2022.
- A 5-year average of -$6.0 million and a median of -$7.6 million in 2022 frame the typical range for EBT.
- Annual changes were most pronounced in 2022 — EBT sank 558.58% — and 2025, when it soared 160.77%.
- Tracing PTN's EBT over 5 years: stood at -$2.0 million in 2022, then sank by 298.67% to -$7.8 million in 2023, then surged by 67.03% to -$2.6 million in 2024, then plunged by 180.88% to -$7.3 million in 2025, then soared by 80.27% to -$1.4 million in 2026.
- The last three EBT figures came in at -$1.4 million (Q1 2026), -$7.3 million (Q4 2025), and $4.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 177.81 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -11.37 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 81.49 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -264.70 Mn |
| 10 | Palatin Technologies | 40.86 Mn | 40.86 Mn | - | -1.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.43 Mn |
| Dec 31, 2025 | -7.26 Mn |
| Sep 30, 2025 | 4.68 Mn |
| Jun 30, 2025 | -2.25 Mn |
| Mar 31, 2025 | -4.78 Mn |
| Dec 31, 2024 | -2.59 Mn |
| Sep 30, 2024 | -7.70 Mn |
| Jun 30, 2024 | -8.25 Mn |
| Mar 31, 2024 | -8.44 Mn |
| Dec 31, 2023 | -7.84 Mn |
| Sep 30, 2023 | -6.05 Mn |
| Jun 30, 2023 | -9.82 Mn |
| Mar 31, 2023 | -8.67 Mn |
| Dec 31, 2022 | -1.97 Mn |
| Sep 30, 2022 | -8.67 Mn |
| Jun 30, 2022 | -12.77 Mn |
| Mar 31, 2022 | -7.63 Mn |
| Dec 31, 2021 | -8.69 Mn |
| Sep 30, 2021 | -7.40 Mn |
| Jun 30, 2021 | 2.78 Mn |